Meningitis is an inflammation of the tissue layers that surround the brain and spinal cord (meninges) as well as the fluid-filled area between the meninges (subarachnoid space). Meningitis can be caused by bacteria, viruses, fungus, or non-infectious illnesses. Meningitis symptoms include headache, fever, and a stiff neck that makes lowering the chin to the chest difficult or impossible, though infants may not have a stiff neck and symptoms may differ in the elderly and individuals who use immune-suppressing medicines. Vaccination is a safe option to develop immunity against meningitis. Immunization of individuals most at risk of being infected helps to protect the individuals from meningitis, prevents its spread within communities, and eventually benefits the entire population. However, not all causes of meningitis and septicemia are vaccine preventable so being able to recognize the symptoms is important.
Market Dynamics
Key companies in the market are focusing on product launches and approvals for meningitis vaccines which is expected to boost the global meningitis vaccines market growth over the forecast period. For instance, in June 2021, CanSinoBIO, an innovative biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has a trade name: Menphecia. Menphecia delivers protection against infection of Group A and C Neisseria meningitides.
Moreover, in May 2019, the Ministry of Health of Ireland had approved the menACWY vaccine to be administered to thousands of children & adults in Ireland due to rising cases of meningitis that were reported in 2018.
Key features of the study:
- This report provides in-depth analysis of the global meningitis vaccines market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global meningitis vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GlaxoSmithKline plc., Sanofi S.A., Merck & Co., Inc., Pfizer Inc., Novartis AG, Walvax Biotechnology Co., Ltd., Incepta Pharmaceuticals Ltd., Serum Institute of India Pvt. Ltd., Vacsera, Zhi Fei Biological, BIO MED, Chengdu Kanghua Biological Products, Bharat Biotech., LG Chem, Espromed Bio, Panacea Biotec Limited, Sinovac Biotech Co., Ltd., CanSinoBIO, and Eubiologics Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningitis vaccines market
Detailed Segmentation:
- Global Meningitis Vaccines Market, By Vaccine:
- Pneumococcal Conjugate Vaccine
- Pneumococcal Polysaccharide Vaccine
- Meningococcal Vaccine
- Others
- Global Meningitis Vaccines Market, By Age Group:
- Global Meningitis Vaccines Market, By Distribution Channel:
- Global Meningitis Vaccines Market, By Country:
- Egypt
- Nigeria
- Morocco
- Indonesia
- Bangladesh
- Malaysia
- United Arab Emirates
- Saudi Arabia
- Pakistan
- Turkey
- Kazakhstan
- Jordan
- Qatar
- Sudan
- Lebanon
- Uganda
- Benin
- Cameroon
- Gabon
- Cote d’Ivoire
- Vietnam
- Singapore
- Mexico
- Argentina
- Thailand
- Philippines
- Nepal
- Myanmar
- Rest of the World
- Company Profiles
- GlaxoSmithKline plc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi S.A.
- Merck & Co., Inc.
- Pfizer Inc.
- Novartis AG
- Walvax Biotechnology Co., Ltd.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd.
- Vacsera
- Zhi Fei Biological
- BIO MED
- Chengdu Kanghua Biological Products
- Bharat Biotech.
- LG Chem
- Espromed Bio
- Panacea Biotec Limited
- Sinovac Biotech Co., Ltd.
- CanSinoBIO
- Eubiologics Co., Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
